Abstract
Stem cell factor (SCF) and its receptor KIT play crucial roles in the differentiation, proliferation, survival, migration, and activation of mast cells. Therefore, highly selective, orally available KIT inhibitors would be beneficial for mast cell-associated diseases.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
